Launched just last year, artificial intelligence-powered drug discovery company X-37 now has raised $14.5 million in Series A financing to expand its development programs. The startup was co-founded by two San Francisco firms: Atomwise, which employs A… […]
Launched just last year, artificial intelligence-powered drug discovery company X-37 now has raised $14.5 million in Series A financing to expand its development programs. The startup was co-founded by two San Francisco firms: Atomwise, which employs A… […]
Valoctocogene Roxaparvovec on Track for US and EU Regulatory Submissions by Year EndVosoritide Sustains Height Gain in Phase 2 Study, Phase 3 Topline Results Expected by Year EndNext Two IND Candidates Identified: 3rd Gene Therapy Candidate in Heredita… […]
You can add one more depression drug trial to the scrap heap of failed clinical explorations.
VistaGen followed its spring failure for AV-101 as a monotherapy with a followup defeat using the therapy as an adjunctive treatment for major depression, add… […]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #AI–Cofounded by Atomwise and Velocity Pharmaceutical Development, X-37 combines a world-class AI platform and experienced pharmaceutical developers. […]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #AI–Cofounded by Atomwise and Velocity Pharmaceutical Development, X-37 combines a world-class AI platform and experienced pharmaceutical developers. […]
Apple on Thursday launched three health studies — focused on mobility, menstruation, and hearing — that aim monitor hundreds of thousands of people via their own iPhones and Apple Watches. […]
In a breakthrough with important implications for the future of immunotherapy for breast cancer, UCSF scientists have found that blocking the activity of a single enzyme can prevent a common type of breast cancer from spreading to distant organs. […]
Some programs work better than others when it comes to involving citizens in preserving the environment. After reviewing those that worked, Stanford researchers propose a blueprint for how others can educate people to maximize their impact. […]
SAN FRANCISCO, Nov. 14, 2019 /PRNewswire/ — Tivic Health™ Systems Inc., a commercial phase bioelectronic company, today announced it has received ISO 13485:2016 certification for its quality management system (QMS), following review by the British … […]
© 2019 San Francisco Biotechnology Network
